Christopher Cannon/LinkedIn
Feb 16, 2026, 13:21
Christopher Cannon: Factor XIa Inhibition Reduces Stroke Risk in Non-Cardioembolic Stroke and High-Risk TIA
Christopher Cannon, Cardiologist at Brigham and Women’s Hospital, Editor-in-Chief of Harvard Heart Letter, shared a post on LinkedIn:
”Factor XIa inhibition works! When added to antiplatelet therapy for non-cardioembolic ischemic stroke or high-risk TIA, XIa inhibition significantly reduced stroke by 26%, with no significant increase in bleeding!”
Title: Next-Generation Factor XIa Cuts Recurrent Stroke Risk by 26%— Asundexian prevented repeat strokes without bleeding side effects
Authors: Nicole Lou
Read the Full Article on MedPage Today։
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 11:42Fonkou Steve: A Moment to Celebrate the Journey Ahead
-
Oct 5, 2026, 11:33Abeeha Faisal: Beyond the Textbooks – A Day With Children Living With Thalassemia
-
Oct 5, 2026, 11:26Jan Zlamal: Honoured with the Fritz Schiff Young Investigator Award by the DGTI
-
Oct 5, 2026, 11:21Umar Mansuri: Can Micronutrient Powders Help Reduce Childhood Anemia?
-
Oct 5, 2026, 11:03Vitalina Dzutseva: Could mRNA Encoded TCEs Transform B Cell Depletion?
-
Oct 5, 2026, 10:50Ligia Carolina Facin: Investigating a Novel Therapeutic Strategy for ATTR-CM
-
Oct 5, 2026, 10:45Mohammed Ayaz Ali։ HIT – When an Anticoagulant Causes Thrombosis
-
Oct 5, 2026, 10:24Vishnu Priya Pulipati: The Endocrinologist’s Role in Lp(a) and Cardiovascular Risk Reduction
-
Oct 5, 2026, 09:59William McKeown – A Busy Week with the European Haemophilia Consortium